Transurethral resection of the prostate: defending its leading position in the management of benign prostatic enlargement.
Although challenged by medical therapy and numerous minimal-invasive treatment modalities, transurethral resection of the prostate (TURP) is still considered as the gold standard of interventional treatment of benign prostatic enlargement (BPE). It is characterized by an immediate improvement in symptoms and voiding parameters and achieves long lasting


RESULTS
While its efficacy is out of question, the associated peri- and postoperative morbidity remains a major point of criticism and has let to the introduction of numerous less invasive treatment options. On the other hand, this also brought various improvements in the technique of TURP aiming to improve treatment results and reduce perioperative morbidity. This review article gives an overview over the historical development, treatment results, associated complications and recent technical developments in TURP, highlighting especially the role of bipolar TURP.
Department of Urology, Hospital Sindelfingen-Böblingen, Germany. g.wendt-nordahl@klinikverbund-suedwest.de
G
G
Wendt-Nordahl
Y
Y
Cao
A
A
Häcker
M S
MS
Michel
T
T
Knoll
D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000601:surgery*; D020728:Transurethral Resection of Prostate / Q000009:adverse effects / Q000379:methods